U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07274787) titled 'Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma' on Nov. 20.
Brief Summary: This study will evaluate the safety and early effectiveness of the NaviFUS system with concomitant microbubble administration in conjunction with BEV in recurrent GBM patients.
Study Start Date: Jan. 01, 2026
Study Type: INTERVENTIONAL
Condition:
GBM
Intervention:
DEVICE: NaviFUS System
The NaviFUS System is a FUS phased array system intended to transcranially deliver burst-mode ultrasound energy with the concurrent microbubble intravenous administration to temporally and locally open the BBB. The NaviFUS System i...